中科電氣(300035.SZ):子公司擬與重慶弗迪共設負極材料合資公司
格隆匯9月2日丨中科電氣(300035.SZ)公佈,公司於2022年9月2日召開第五屆董事會第十五次會議,審議通過《關於公司全資子公司與重慶弗迪簽署合資經營協議暨設立合資公司的議案》,同意公司全資子公司湖南中科星城科技有限公司(簡稱“中科星城科技”)與重慶弗迪鋰電池有限公司(簡稱“重慶弗迪”)簽署《合資經營協議》,雙方擬確定戰略合作關係,併合作設立合資公司,合資公司註冊資本為10億元人民幣,其中,中科星城科技或其控股子公司認繳6.5億元,重慶弗迪或其控股子公司認繳3.5億元,該合資公司將專注於負極材料製造,並優先向重慶弗迪及其關聯方供應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.